Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals Private Limited - trading in Thanjavur, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24233TN2012PTC086070 Incorporated 28 May 2012 ROC Chennai HQ Thanjavur, Tamil Nadu, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2024
₹12.79 Lakh
▼ 33% YoY
Net profit · FY 2024
₹19,693
Net margin 1.5%
EBITDA · FY 2024
₹44,068
EBITDA margin 3.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Astran Pharmaceuticals Private Limited

Data last updated:

Astran Pharmaceuticals Private Limited is a private limited company based in Thanjavur, Tamil Nadu, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 May 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24233TN2012PTC086070. Its GSTIN is 33AAKCA6197P1ZY (Tamil Nadu).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Thirugnanam Anbarasan (Managing Director) and Thirugnanam Anantha Raj.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No:1915 South New Street Manojipatti Post Medical College Road, Thanjavur, Tamil Nadu, India – 613004.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.79 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹19,693 (net margin 1.5%) and EBITDA of ₹44,068 (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Astran Pharmaceuticals Private Limited
CIN U24233TN2012PTC086070
Registration Number 086070
Incorporation Date 28 May 2012
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    No:1915 South New Street Manojipatti Post Medical College Road, Thanjavur, Tamil Nadu, India – 613004
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
Astran Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Astran Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Astran Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Astran Pharmaceuticals Private Limited

The main business activity of Astran Pharmaceuticals is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Astran Pharmaceuticals Private Limited FY 2025 filings available

Astran Pharmaceuticals Private Limited reported revenue of ₹12.79 Lakh (down 33% YoY) for FY 2024.

Revenue · FY 2024
₹12.79 Lakh ▼ 33%
Net profit · FY 2024
₹19,693 margin 1.5%
EBITDA · FY 2024
₹44,068 margin 3.4%

Compounded Annual Growth Rate (CAGR) of Astran Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 33%
3 years · compounded
▲ 3%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 29%
5 years · compounded
▲ 18%

Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 33% fall in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Astran Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹44,068••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹19,693••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Astran Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.4%••••••••••••••••
Net Profit Margin1.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Astran Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Stile Pharmaceuticals Private Limited₹12.88 Lakh (FY 2024)••••••••-9.0%••••Thane, Maharashtra, India
D Cross Pharmaceuticals Private Limited₹12.86 Lakh (FY 2025)••••••••34.0%••••Delhi, India
Bionek Pharmaceuticals Private Limited₹12.85 Lakh (FY 2025)••••••••5.0%••••Varanasi, Uttar Pradesh, India
Aysha Davakhana Ayurveda Pharmaceuticals Private Limited₹12.82 Lakh (FY 2025)••••••••176.0%••••Vatakara, Kerala, India
Jodeera Pharmaceuticals Private Limited₹12.81 Lakh (FY 2022)••••••••216.0%••••Jalgaon, Maharashtra, India
Astran Pharmaceuticals Private Limited this company₹12.79 Lakh (FY 2024)••••••••-33.0%••••Thanjavur, Tamil Nadu, India
Immunex Pharmaceuticals Private Limited₹12.77 Lakh (FY 2025)••••••••-38.0%••••Mumbai, Maharashtra, India
Minecure Pharmaceuticals Private Limited (OPC)₹12.74 Lakh (FY 2020)••••••••3335.0%••••Bhubaneswar, Odisha, India
Yanelly Pharmaceuticals Private Limited₹12.73 Lakh (FY 2024)••••••••10.0%••••Bhopal, Madhya Pradesh, India
Medniqa Pharmaceuticals Private Limited₹12.72 Lakh (FY 2025)••••••••1320.0%••••Ahmedabad, Gujarat, India
Redsear Pharmaceuticals Private Limited₹12.72 Lakh (FY 2025)••••••••-21.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Astran Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals Private Limited is audited by S VENKATARAMAN for the financial year 2017.

NameStatusAppointment DateCessation Date
S VENKATARAMANLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Thirugnanam Anantha RajDirector28 May 201214 Years 4 MonthsCurrent
Thirugnanam AnbarasanManaging Director28 May 201214 Years 4 MonthsCurrent

Ownership and Shareholding of Astran Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Astran Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Astran Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Thirugnanam Anantha Raj was appointed as Director on 28 May 2012.

AGM
Astran Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Astran Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Thirugnanam Anantha Raj was appointed as Director.
Appointed
Thirugnanam Anbarasan was appointed as Managing Director.
Incorporation
28 May 2012
Astran Pharmaceuticals Private Limited was registered on 28 May 2012 with Roc Chennai & aged 14 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Astran Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Astran Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Astran Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAKCA6197P1ZYTamil NaduActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Astran Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Astran Pharmaceuticals Private Limited

Astran Pharmaceuticals is an active private limited company based in Thanjavur, Tamil Nadu, India. The company works in wholesale, within the trading industry. It was incorporated on 28 May 2012 (14+ years old) and is registered under CIN U24233TN2012PTC086070.

Astran Pharmaceuticals reported revenue of ₹12.79 Lakh for FY 2024 (down 33% YoY).

Astran Pharmaceuticals has 2 current directors:

Astran Pharmaceuticals reported a net profit of ₹19,693 (net margin 1.5%) and EBITDA of ₹44,068 (EBITDA margin 3.4%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Astran Pharmaceuticals is 3% over three years and -6% over five years. In the latest year (FY 2024) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Astran Pharmaceuticals is 33AAKCA6197P1ZY, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Astran Pharmaceuticals is U24233TN2012PTC086070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Astran Pharmaceuticals was incorporated on 28 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Astran Pharmaceuticals by revenue are Stile Pharmaceuticals Private Limited, D Cross Pharmaceuticals Private Limited, Bionek Pharmaceuticals Private Limited, Aysha Davakhana Ayurveda Pharmaceuticals Private Limited, Jodeera Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Thirugnanam Anantha Raj was appointed as Director on 28 May 2012. Thirugnanam Anbarasan was appointed as Managing Director on 28 May 2012.

The registered office of Astran Pharmaceuticals is at No:1915 South New Street Manojipatti Post Medical College Road, Thanjavur, Tamil Nadu, India – 613004.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available